NCT06500234View on ClinicalTrials.gov

Nutrition Impact on Immunotherapy of Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2027

Conditions
Nutrition DisordersImmunotherapyCancerSurvival, Prosthesis
Interventions
DRUG

Megestrol Acetate and olanzapine

megestrol acetate, 160 mg, oral everyday; olanzapine 2.5 mg, oral everyday

DRUG

Starch powder 50 mg

Starch powder 50 mg, oral, everyday

Trial Locations (1)

266042

RECRUITING

Qingdao Central Hospital, Qingdao

All Listed Sponsors
lead

Qingdao Central Hospital

OTHER